New Jersey A 1322: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2024-01-09)

State: New Jersey · Session: 221 · Bill: A 1322

Subjects: DISEASE, HEALTH PROF

Sponsors: DePhillips, Christopher P.

View New Jersey A 1322 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.